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Canine Mesenchymal Stem Cell Bone Regenerative Capacity is Regulated by Site-
Specific Multi-Lineage Differentiation 
Abstract 
Objectives 
Mesenchymal stem cells (MSCs) are promising therapies in dentistry due to their multipotent properties. 
Selecting donor MSCs is crucial because beagle dogs (canines) commonly used in pre-clinical studies 
have shown variable outcomes and it is unclear whether canine MSCs (cMSCs) are skeletal site-specific. 
This study tested whether jaw and long bone cMSCs have disparate in vitro and in vivo multilineage 
differentiation capabilities. 
Study Design 
Primary cMSCs were isolated from mandible (M-cMSCs) and femur (F-cMSCs) of four healthy Beagle 
dogs. Femur served as non-oral control. Clonogenic and proliferative abilities were assessed. In 
vitroosteogenic, chondrogenic, adipogenic and neural multilineage differentiation were correlated with in 
vivobone regeneration and potential for clinical applications. 
Results 
M-cMSCs displayed two-fold increase in clonogenic and proliferative capacities relative to F-cMSCs (p 
=0.006). M-cMSCs in vitro osteogenesis based on alkaline phosphatase (p =0.04), bone sialoprotein (p 
=0.05), and osteocalcin (p =0.03), as well as adipogenesis (p =0.007), and chondrogenesis (p =0.009) 
were relatively higher and correlated with enhanced M-cMSC bone regenerative capacity. Neural 
expression markers, nestin and βIII-tubulin were not significantly different. 
Conclusions 
The enhanced differentiation and bone regenerative capacity of mandible MSCs may make them 
favorable donor graft materials for site-specific jaw bone regeneration. 
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Abstract
Objectives—Mesenchymal stem cells (MSCs) are promising therapies in dentistry due to their 
multipotent properties. Selecting donor MSCs is crucial because beagle dogs (canines) commonly 
used in pre-clinical studies have shown variable outcomes and it is unclear whether canine MSCs 
(cMSCs) are skeletal site-specific. This study tested whether jaw and long bone cMSCs have 
disparate in vitro and in vivo multilineage differentiation capabilities.
Study Design—Primary cMSCs were isolated from mandible (M-cMSCs) and femur (F-
cMSCs) of four healthy Beagle dogs. Femur served as non-oral control. Clonogenic and 
proliferative abilities were assessed. In vitro osteogenic, chondrogenic, adipogenic and neural 
multilineage differentiation were correlated with in vivo bone regeneration and potential for 
clinical applications.
Results—M-cMSCs displayed two-fold increase in clonogenic and proliferative capacities 
relative to F-cMSCs (p =0.006). M-cMSCs in vitro osteogenesis based on alkaline phosphatase (p 
=0.04), bone sialoprotein (p =0.05), and osteocalcin (p =0.03), as well as adipogenesis (p =0.007), 
and chondrogenesis (p =0.009) were relatively higher and correlated with enhanced M-cMSC bone 
regenerative capacity. Neural expression markers, nestin and βIII-tubulin were not significantly 
different.
Conclusions—The enhanced differentiation and bone regenerative capacity of mandible MSCs 
may make them favorable donor graft materials for site-specific jaw bone regeneration.
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Introduction
Careful selection of donor tissue for oral bone regeneration is vital for successful graft 
therapy. Translational studies aimed at improving clinical outcomes commonly use beagle 
dogs as experimental animals for tissue transplant studies because of their docile nature 1–3. 
Selecting optimum donor graft material for orofacial bone regeneration is still a challenge 
that causes unpredictable clinical outcomes 4, 5. While different donor graft materials have 
been tested, the modulatory effects induced by skeletal site-specific multilineage 
differentiation capabilities of jaw-specific orofacial mesenchymal stem cells (MSCs) are yet 
to be fully clarified. MSCs are unique population of multipotent postnatal stem cells that can 
be isolated from different tissues.6 MSCs have the ability to form multiple tissue types such 
as bone, cartilage, muscle, nerve, tendon and fat. However, they also show significant 
differences in ex vivo expansion potential and functions based on age and skeletal-site of 
origin.7–9 Current pre-clinical applications of MSCs have focused extensively on human, 
mouse and rat MSCs although MSCs have also been isolated from unconventional animal 
models like dogs, pigs, cats, sheep and goat. 10 Interestingly, phenotypic and functional 
skeletal site-disparities have been reported in human and murine MSCs. 7, 10–12 These 
previous studies demonstrated that orofacial MSCs isolated from the jaw display superior 
osteogenic capacities relative to those isolated from the hip and long bones. The MSC 
functional site disparities were alluded to evolutionary adaptations at each skeletal site and 
neuro-ectodermal developmental origin of jaw bones that is distinct from mesodermal origin 
of spine and hip bones.7, 11 How these modulate oral bone regeneration is yet to be fully 
elucidated.
The skeletal site-specific functional differences of MSCs are not limited to humans and 
rodents as other animal models such as dogs may display similar site-disparity. Also, it is 
unclear if dog (canine) MSCs inherently display skeletal site-specific functional differences. 
Although beagle dogs have been used in pre-clinical studies to model oral bone loss or 
regeneration, the effects of jaw-specific properties of cMSCs have not been clearly defined. 
This study tested the hypothesis that canine MSCs from the jaw and long bones have 
disparate in vitro and in vivo multilineage differentiation capabilities. It is expected that 
further understanding of underlying biological and genetic differences would enhance MSC-
based donor graft selection for bone regeneration.13–16
Materials and Methods
Isolation and culture of canine mesenchymal stem cells
Freshly isolated trabecular bone samples were obtained from both the mandible and femur 
of four female 3-week-old normal healthy beagle dogs from an in-house breeding colony 
cared for according to National Institutes of Health (NIH) and United States Department of 
Agriculture (USDA) guidelines of the care and use of research animals. The Institutional 
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Animal Care and Use Committee of University of Pennsylvania Office of Regulatory Affairs 
approved all animal protocols. Primary culture of canine mesenchymal stem cells (cMSCs) 
were established in culture from the mandible and femur as previously described 7 using α-
modified Minimum Essential Medium (α-MEM, Life Technologies, Grand Island NY) 
supplemented with 20% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA), 100 
U/ml penicillin, 100 mg/ml streptomycin sulfate and 2 mM glutamine. The culture was 
maintained at 37°C humidified atmosphere of 5% CO2 and air. Primary cMSCs isolated 
from the mandible (M-cMSCs) and femur (F-cMSCs) were further sub-cultured, expanded 
and stored in liquid nitrogen until used. The cMSCs used for all experiments were within 
passages 2 to 5. M-cMSCs and F-cMSCs for each individual animal were tested together.
Colony forming efficiency and survival of cMSCs
Colony forming efficiency based on colony forming units-fibroblasts (CFU-F) was assessed 
as previously described by seeding 101, 102 and 103 passage 2 F-cMSCs and M-cMSCs in 
triplicate 25cm2 plastic culture flasks. 7, 16 At 14 days, the cells were fixed in 100% 
methanol, stained with methyl violet and colonies of 50 or more cell aggregates representing 
CFU-Fs were counted. Cell proliferation was assessed based on growth curve analysis of 
cMSCs plated in 6-well plates at 9.5 × 103 cells/cm2. The cells were trypsinized and counted 
on days 1, 3, 6, 9, 12, and 15 to plot a growth curve. Proliferation was analyzed using non-
linear regression curve fitting of surviving F-cMSCs and M-cMSCs (GraphPad Prism v6 
(GraphPad Software Inc. La Jolla CA).
Long-term survival of cMSCs was assessed by population doublings (PD) as previously 
described. 7 Both cMSCs types were plated in T-25 flasks at 1 × 106 cells/flask, and PD was 
calculated based on cell number after repeated cell passage at 1:10 split ratio until the cells 
attained replicative senescence. Nuclear extracts at each serial passage were isolated with 
Nuclei EZ Prep® (Cat # NUC-101, Sigma-Aldrich, St Louis, MO) following the 
manufacturer’s protocol. Telomerase activity was determined by western blotting of equal 
protein amounts immunoreacted with rabbit anti-cTERT primary antibody (1: 1000 dilution, 
Cat # NB110-89471, Novus Biologicals, Littleton, CO). Rabbit anti-β-actin (1:2000) (Cat # 
4967, Cell Signaling Technology, Danvers MA) served as loading control. Bound antibodies 
were detected with horseradish peroxidase linked donkey anti-rabbit IgG as secondary 
antibody (1: 2000 dilution, Cat # NA934V, GE Healthcare Life Sciences, Piscataway, NJ). 
Immunoreactive bands were digitized and analyzed with ImageJ v1.49g (National Institutes 
of Health, Bethesda MD).
In vitro osteogenic differentiation
Osteogenic differentiation was performed as previously described. 15, 16 F-cMSCs and M-
cMSCs were cultured at 1 × 104 cells/cm2 in ten 60mm dishes (Corning Life Sciences, 
Tewksbury, MA). Five of the dishes were pre-coated with poly-L-lysine (Sigma-Aldrich) to 
enhance plastic adherence under long-term culture. At confluence, the cMSCs seeded in 
coated dishes were switched to α-MEM medium supplemented with 100 ng/ml of human 
bone morphogenetic protein-2 (BMP-2, GenScript, Piscataway, NJ, USA) and 100 μM L-
Ascorbic acid 2-phosphate (10−4 M). Medium was changed twice weekly for 7 and 14 days 
after which protein lysate and RNA were collected in parallel experimental culture dishes. 
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Total protein was determined using the bicinchoninic acid protein assay (Pierce™ BCA 
Protein Assay Kit, Thermo Scientific, Rockford IL). Equal protein amount was loaded on a 
4 – 20% gradient gel, transferred to nitrocellulose membrane for western blotting and 
probed with the following primary antibodies: rabbit anti-bone sialoprotein (BSP) polyclonal 
antibody (Bioss Inc. Worburn MA) at 1:200; rabbit anti-osteocalcin (OCN) polyclonal 
antibody (Bioss Inc. Worburn MA) at 1:200, and rabbit anti-alkaline phosphatase (ALP) 
antibody (Novus Biologicals) at 1:800. Either anti-β-actin (1:1000) or anti-α-tubulin (1:200) 
served as loading control. Secondary antibodies included anti-mouse or anti-rabbit 
antibodies at concentrations ranging from 1:1000 – 1:3000. Immunoreactive bands were 
digitized followed by quantification with ImageJ v1.49g (National Institutes of Health, 
Bethesda MD). Real time PCR was performed with ABI 7300 Real-Time PCR System using 
Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) as previously 
described. 17 Total RNA was isolated and first strand cDNA was prepared using custom 
designed primers that include: canine BSP (forward primer 5′-TTG CTC AGC ATT TTG 
GGA ATG G-3′; reverse primer 5′-AAC GTG GCC GAT ACT TAA AGA CC-3′); canine 
OCN (forward primer 5′-CTG GTC CAG CAG ATG CAA AG-3′; reverse primer 5′-CCG 
CTT GGA CAC GAA GGT T-3′); and canine ALP (forward primer 5′-TTC AAA CCG 
AGA CAC AAG CAC T-3′; reverse primer 5′-GGG TCA GTC ACG TTG TTC CTG T-3′). 
Gene expression levels were normalized to the housekeeping gene: canine β2 microglubulin 
(forward primer 5′-TCA CGA CAC CCA GCA GAG AA-3′; reverse primer 5′-GGA ACC 
CTG ACA CGT AGC AGT T-3′.
In vivo osteogenic differentiation
Bone regenerative capacity of F-cMSCs and M-cMSCs was assessed by transplantation of 1 
× 106 cells attached to hydroxyapatite-tricalcium phosphate (HA/TCP, Zimmer Inc. Warsaw, 
IN) into the subcutis of 6-week old immunocompromised mice (NIH-III NU, Charles River 
Laboratories, Wilmington, MA) as previously described. 7 At 12 weeks, transplants were 
harvested, fixed in 4% paraformaldehyde, decalcified in 10% EDTA (pH 8.0) and paraffin-
embedded for histological analysis. Images were captured with Nikon Eclipse80i fluorescent 
microscope (Nikon Instruments, Melville, NJ) and bone regeneration was assessed using an 
established semi-quantitative bone scoring system. 7
Adipogenic differentiation
F-cMSCs and M-cMSCs were cultured at 1.8 × 103 cells/cm2 in 4-well chamber slides 
(Coming Life Sciences, Acton, MA) and at confluence, adipogenic differentiation was 
induced as previously described 7, 16 using adipogenic differentiation medium composed of 
α-MEM supplemented with 10−8 M dexamethasone, insulin (1 μg/ml), 1-methyl-3-
isobutylxanthine (IBMX, 5 × 10−8 M), indomethacin (10−4 M), and fetal bovine serum 
(10%) for 15 days. Control cells were not induced with adipogenic medium. Medium was 
refreshed twice weekly. At day 15, the cells were fixed with 4% paraformaldehyde, stained 
with 0.3% Oil Red O and counterstained with 1% Fast green dye. Lipid laden cells were 
evaluated and quantified microscopically.
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Chondrogenesis
F-cMSCs and M-cMSCs were cultured in 75 cm2 flasks at 75 × 104 cells/cm2 until 80–90% 
confluent. Subsequently, 2 × 106 cells were transferred and pelleted in a 15 ml 
polypropylene tube as previously described. 16, 18, 19 The pelleted cells were induced with 
chondrogenic medium consisting of α-MEM supplemented with 10−8 M dexamethasone, 
1% ITS+, 10−4 M L-Ascorbic acid 2-phosphate, 10 ng/ml transforming growth factor-beta 3, 
10 mM β-glycerophosphate, 2 mM, glutamine, 100 U/ml penicillin-streptomycin sulfate, 2 
mM pyruvate and medium change every 3 days. Pelleted control cells were exposed to α-
MEM without chondrogenic inducers. The pellets were harvested after 4 and 8 weeks, fixed 
with 4% paraformaldehyde, and paraffin-embedded 5 μm sections were stained with Alcian 
blue plus counterstain of nuclear fast red for histological analysis.
Neural differentiation
Collagen coated 8-well chamber slides (Corning® BioCoat™, Corning Life Sciences, 
Tewksbury, MA) were seeded with F-cMSCs and M-cMSCs at 4 × 103 cells/cm2 using α-
MEM growth medium until confluent. Control cells were continuously maintained in the 
same growth medium, but the neurogenically induced cMSCs were switched to a pre-
induction medium consisting of α-MEM fortified with 10 ng/ml β-fibroblast growth factor 
(β-FGF, BD Biosciences, San Jose CA). After 24 hours, the pre-induction medium was 
switched to neuronal induction medium consisting of α-MEM supplemented with 20% fetal 
bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin sulfate, 2 mM glutamine, 2% 
dimethyl sulfoxide, 10 ng/ml β-FGF, 200 μM butylated hydroxyanisole, 10 μM forskolin, 25 
mM KCl, 2 mM valproic acid and 5 μg/mL insulin. Neural differentiation was evaluated at 7 
and 14 days by immunofluorescent staining using primary antibodies of rabbit anti-nestin 
(1:200) (LifeSpan BioSciences, Inc. Seattle WA) and rabbit anti-βIII-tubulin (1:200) (Bioss, 
Woburn MA) as primary antibodies. Alexa Fluor® 555 Goat Anti-Rabbit IgG (Life 
Technologies, Grand Island NY) served as secondary antibody and nuclei were stained with 
1 μg/ml of Hoechst 33342. Images were captured with Nikon Eclipse80i fluorescent 
microscope (Nikon Instruments, Melville, NJ).
Statistical analysis
Each cell type was plated in triplicates with appropriate controls. Each experiment was 
performed independently and repeated at least three times. Results were expressed as mean 
± standard deviation. Effects of differentiation media were presented as fold-change relative 
to control un-induced cMSCs. Although M-cMSCs and F-cMSCs for each individual animal 
were tested together, data from the animals (n = 4) were pooled for statistical analysis 
performed with GraphPad Prism v6 (GraphPad Software Inc. La Jolla CA). Comparative 
analysis of the animals’ F-cMSCs and M-cMSCs differential responses was performed by 
two-way analysis of variance (ANOVA) followed by post-hoc comparisons with Holm-Sidak 
test and statistical significance was set at p<0.05.
Results
We isolated cMSCs from the mandible and femur trabecular bone samples obtained from 
beagle dogs commonly used for translational studies 15 The monolayer of primary F-cMSCs 
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and M-cMSCs demonstrated heterogeneous fibroblast-like morphological shapes and sizes 
characteristic of MSCs (data not shown). M-cMSCs displayed significantly higher time-
dependent proliferation (p = 0.006) that peaked on day 12 compared with F-MSC 
proliferation that peaked on day 9 (Figure 1A). The colony forming capacities based on 
CFU-Fs were not different between the two cell types (Figure 1B), however, population 
doubling showed there were more doubling M-cMSCs at early passages than F-cMSCs 
(Figure 1C). The F-cMSCs also underwent complete senescence after passage 6 unlike M-
cMSCs that displayed gradual senescence up to passage 12. The apparently delayed 
senescence of M-cMSCs was supported by higher expression levels of cTERT (Figure 1D 
and E).
Analysis of osteogenic proteins that include ALP, BSP, and OCN by western blotting at 14 
days post-induction (Figures 2) showed strong immunoreactivity suggestive of a strong 
osteogenic responsiveness of cMSCs from both skeletal sites. The amounts of ALP (Figures 
2C), BSP (Figures 2D) and OCN (Figure 2E) were disproportionately higher in M-cMSCs 
relative to F-cMSCs (ALP, p = 0.04; BSP, p= 0.05 and OCN, p=0.03). At the mRNA level, 
the M-cMSC transcripts of osteogenic markers ALP (p < 0.001), BSP (p < 0.001) and OCN 
(p< 0.001) (Figures 2F – H respectively) were even much more upregulated relative to F-
cMSCs. Analysis of in vivo bone regenerative ability of F-cMSCs (Figure 3A, B, E) and M-
cMSCs (Figures 3C, D, F) was assessed semi-quantitatively on a scale of 0 to 4 based on a 
previously established scoring system. 7 This showed that M-cMSCs can regenerate 
appreciably more bone quantitatively than F-cMSCs with or without the addition of 
osteogenic inducers (Figures 3E and F). Hence, the F-CMSCs needed osteogenic induction 
to regenerate the similar quantitatively appreciable bone (Figure 3E, p < 0.05) as 
unstimulated M-cMSCs. Also, exposure of F-MSCs to osteogenic medium induced 
formation of marrow components (hematopoiesis and adipocytes, Figure 3B) while bone 
formed by M-cMSCs were within a fibrous tissue bed (Figure 3D).
After induction with adipogenic medium, the M-cMSCs responded by displaying more 
lipid-laden cytoplasmic contents (p = 0.007) based on Oil-Red O staining (Figure 4A – E). 
Similarly, assessment of chondrogenesis by the pellet culture method clearly indicated that 
M-cMSCs were more responsive to chondrogenic stimulation (p = 0.009) based on Alcian 
blue staining of chondrocyte-like cells (Figure 4F – J). After exposure to neuronal 
differentiation medium, both F-cMSCs (Figures 5A and C) and M-cMSCs (Figures 5B and 
D) displayed strong immunoreactivity to anti-nestin (at 7 days) and anti-β-III tubulin (at 14 
days) without appreciable differences between the two cell types. Nestin immunoreactivity 
(Figure 5A, B) revealed that the cells adopted spindle shaped morphology with stretched-out 
dendrite-like cytoplasmic projections.
Discussion
MSCs have been isolated from bone and other tissues such as canine adipose tissue, 20–25 
umbilical cord blood and tissue, 26 dental pulp, 27 periodontal ligament, 28 amniotic fluid, 29 
muscle, 20 and periosteum. 20 However, direct comparison of two different skeletal sites in 
dogs and clinical implications have not been conclusively evaluated. We used plastic 
adherence method to successfully isolate a population of cMSCs from mandible and femur 
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of the same dogs 30. Although cMSCs isolated from both sites displayed heterogeneous 
fibroblast-like morphology, cell surface labeling and flow cytometric analysis were not 
carried out due to limited starting tissue samples from each animal. 31 To expand MSCs for 
clinical applications, clonogenic capacity is a common MSC characteristic that affects 
multilineage differentiation. We found no significant clonogenic differences between F-
cMSCs and M-cMSCs unlike previously reported human MSC studies, 7. However, M-
cMSCs displayed higher survival and population doubling properties that were associated 
with a more sustained telomerase expression consistent with previous reports on both human 
and murine OFMSCs. 32, 33
The case for use of M-cMSC as viable donor graft for oral bone regeneration is strongly 
supported by the fact that M-cMSCs differentiated much more readily into osteogenic, 
chondrogenic and adipogenic lineages than F-cMSCs in spite of similar neuronal 
differentiation. Additionally, osteogenesis of M-cMSCs appeared to be higher than that of F-
cMSCs based on protein levels and transcripts of osteogenic markers ALP, BSP, and 
OCN. 34
Osteoresponsiveness of cMSCs was also better activated when dexamethasone/ascorbate 
combination in the osteoinductive medium was replaced with combination of BMP-2/
ascorbate. This is in line with previous report that the combination of BMP/ascorbate 
effectively induces alkaline phosphatase in MSCs isolated from young dogs. 15 A strong in 
vitro osteogenesis of human OFMSCs has also been shown to translate into high in vivo 
bone regenerative capacity. 7, 11 Similarly, in vivo bone regenerative capacity of M-cMSCs 
was slightly enhanced with or without stimulation. This indicates that M-cMSCs are 
inherently osteogenic without the need for pre-induction, a factor that favors their use as 
donor grafts for oral bone regeneration. 15, 16, 35 The fact that in vivo bone regenerated by 
transplanted F-cMSCs displayed similar histological features of hematopoiesis and 
adipogenesis as normal femur bone further point to the site-specificity of MSCs and added 
functional demand on these cells 7, 11 This also emphasizes that based on functional 
demand, MSCs formed bone similar to their site of harvest which makes M-cMSCs more 
favorable for oral bone regeneration
Both adipogenesis and chondrogenesis were higher in M-cMSCs relative to F-cMSCs in 
sharp contrast to higher adipogenic differentiation of human iliac crest MSCs relative to 
mandible and maxilla MSCs previously reported. 7 Since chondrogenesis was not addressed 
in the earlier studies 7, 11, 36 follow up studies on site-dependent expression levels of genetic 
markers of adipogenesis and chondrogenesis should give further insights into cMSC site-
selectivity. 16, 22, 25, 26
A higher propensity of M-cMSCs for neuronal differentiation would have been logical since 
mandible bone in which the M-cMSCs reside develops embryologically from 
neuroectoderm, but there were no differences in the neuronal differentiation properties of F-
cMSCs and M-cMSCs. This is an indication that some similarities also exist between the 
two cell types. MSC neuronal morphological changes can be confused with cellular changes 
in response to chemical stress and cytotoxic effects of the induction medium. 37 To minimize 
this confounding effect, we used the two-step neuronal induction protocols that included 
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pre-induction initially with β-fibroblast growth factor (β-FGF) to minimize MSC damage by 
chemical stress. 38, 39 Additionally, we confirmed the neuronal differentiation based on 
positive immunoreactivity with nestin and βIII-tubulin, two known markers of neurogenesis. 
As rodent MSCs have been shown to spontaneously express nestin; 40, 41 it was not 
surprising that non-induced cMSCs also displayed some degree of immunoreactivity to these 
markers (data not shown).
Several factors make a case for assessing skeletal site-specificity of MSCs and their specie-
to-specie differences. The unique neuroectodermal origin of orofacial bones, and 
intramembranous ossification pattern of mandible coupled with endochondral contributions 
from Meckel’s, coronoid and condylar cartilages make the jaw bones developmentally 
different. 42 Furthermore, several bone pathologies display unique radiological and 
histological features in the jaw. These include fibrous dysplasia of bone 43 cherubism 44 and 
hyperparathyroid jaw tumor syndrome. 45 Additionally, long-term use of bone 
antiresorptives is often complicated by jaw osteonecrosis while non-oral bones are spared.46 
Since dogs readily develop jaw osteoradionecrosis, 47, 48 it is not unlikely that they may be 
susceptible to the same pathological features as humans because dogs are exposed to similar 
external and environmental factors as humans.
The results presented in this study have some limitations and therefore represents a pilot 
analysis. Firstly, the cMSCs characterized were isolated from a convenient sample of healthy 
dogs in an unrelated research project; secondly, the number of tissue samples was limited; 
and thirdly, a single breed of dogs was evaluated. Therefore, accessibility to cMSCs from a 
large number of study samples from different breeds of dogs will shed more light on the site-
specificity of MSCs characteristics in dogs. Although, the actions of the components of the 
in vitro osteogenesis-inducing medium have been well defined, 49 it is still unclear if these 
really recapitulate the native environment that promotes in vivo osteogenesis. 50 For 
example, the MSC/HATCP grafted in the subcutis of immunocompromised hosts 
purportedly promotes secretion of vascular endothelial growth factor that induces formation 
of vasculature, which in turn invades the graft. While tissue vascularization is important for 
MSC survival and subsequent osteogenesis, these sequences of events are yet to be clearly 
defined. 13, 51
In spite of the study limitations, these results are consistent with data from studies focused 
on human, mouse and rat MSCs. 7, 11, 36, 52 They enhance our understanding of cMSCs 
including skeletal site-specificity of MSC in general. Our data demonstrated that 
cryopreserved cMSCs could be expanded and differentiated. They also showed that M-
cMSCs are relatively more responsive to multi-lineage differentiation than F-cMSCs and 
represent superior donor graft materials for oral bone regeneration.
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Figure 1. Proliferation and survival of canine MSCs
M-cMSCs display significantly higher proliferation (p =0.006) before peaking on day 12 
compared with F-cMSCs that peaked on day 9 (A). The colony forming capacities based on 
CFU-Fs were not different between the two cell types (B), population doubling capacity of 
M-cMSCs showed there were more doubling cells in the early passages (C). Also, F-cMSCs 
underwent complete senescence after passage 6 unlike M-cMSCs that did not completely 
senesce until passage 12. The delayed senescence of M-cMSCs was supported by higher 
expression levels of cTERT (D and E).
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Figure 2. In vitro osteogenic responsiveness of cMSCs
Analysis of osteogenic proteins by western blotting 14 days post-induction (A, B) showed 
strong immunoreactivity suggestive of osteogenic responsiveness of cMSCs. M-cMSC 
expression levels of three markers of osteogenesis ALP (C), BSP (D) and OCN (E) were 
higher relative to F-cMSCs (ALP, p = 0.04; BSP, p= 0.05 and OCN, p=0.03). At the mRNA 
level, the M-cMSC transcripts of ALP (p < 0.001; F), BSP (p < 0.001; G) and OCN (p< 
0.001; H) were also significantly upregulated. [ALP = alkaline phosphatase; BSP = 
bonesialoprotein; OCN = osteocalcin].
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Figure 3. In vivo osteogenic responsiveness of cMSCs
Both F-cMSCs (A, B) and M-cMSCs (C, D) formed histologically appreciable in vivo bone 
when transplanted into subcutis of immunocompromised host. Semi-quantitative analysis (E, 
F) confirmed that F-cMSCs needed exposure to osteogenic medium to form quantitatively 
appreciable bone (p < 0.05) as non-induced M-cMSCs. The exposure of F-MSCs to 
osteogenic medium induced formation of marrow components [hematopoiesis (Hp) and 
adipocytes (Adp)] (B) while bone formed by M-cMSCs were within a fibrous tissue (FT) 
bed (D).
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Figure 4. Adipogenic and chondrogenic differentiation of cMSCs
Following induction with adipogenic medium, the M-cMSCs responded by showing more 
lipid-laden cells (p= 0.007) based on Oil-Red O staining (Figure 4A – E). Similarly, 
assessment of chondrogenesis using the pellet culture method clearly indicated that M-
cMSCs were more responsive to chondrogenic stimulation (p=0.009) based on Alcian blue 
staining of chondrocyte-like cells (Figure 4F – J). [Representative images are presented in A, 
B, C, D, F, G, H, and I].
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Figure 5. Neuronal differentiation
After exposure to neuronal differentiation medium both F-cMSCs (A, C) and M-cMSCs (B, 
D) were strongly immunoreactive to antibodies to nestin (day 7) and β-III tubulin (day 14). 
Based on nestin immunoreactivity (A, B), both cell types displayed spindle shaped 
morphology with stretched-out dendrite-like cytoplasmic projections [Representative 
immunostaining images are presented].
Bugueño et al. Page 17
Oral Surg Oral Med Oral Pathol Oral Radiol. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
